ACM
PBYI icon

Atika Capital Management’s Puma Biotechnology PBYI Stock Holding History

Atika Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-62,000
Closed -$3.67M – 108
2018
Q2 		$3.67M Buy
+62,000
New +$3.59M 1.06% 54
2015
Q1 		– Sell
-2,500
Closed -$473K – 78
2014
Q4 		$473K Buy
+2,500
New +$555K 0.37% 62
2014
Q2 		– Sell
-11,350
Closed -$1.18M – 78
2014
Q1 		$1.18M Buy
11,350
+8,450
+291% +$993K 1.12% 42
2013
Q4 		$300K Buy
+2,900
New +$170K 0.29% 58

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return